Related references
Note: Only part of the references are listed.Economic evaluation of occupational therapy in Parkinson's disease: A randomized controlled trial
Ingrid H. W. M. Sturkenboom et al.
MOVEMENT DISORDERS (2015)
Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013
Vincent Low et al.
PARKINSONISM & RELATED DISORDERS (2015)
Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and Germany
Evelyn Walter et al.
JOURNAL OF MEDICAL ECONOMICS (2015)
Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson's Disease in The Netherlands
Job F. M. van Boven et al.
DRUGS & AGING (2014)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease
Simon Eggington et al.
JOURNAL OF NEUROLOGY (2014)
Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients
Christofer Lundqvist et al.
JOURNAL OF NEUROLOGY (2014)
Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease
Richard Dodel et al.
MOVEMENT DISORDERS (2014)
Cost of Deep Brain Stimulation for the Treatment of Parkinson's Disease by Surgical Stimulation Sites
Kevin T. Stroupe et al.
MOVEMENT DISORDERS (2014)
Quality of Life and Costs in Parkinson's Disease: A Cross Sectional Study in Hungary
Gertrud Tamas et al.
PLOS ONE (2014)
Cost-Effectiveness of Subthalmic Nucleus Deep Brain Stimulation for the Treatment of Advanced Parkinson Disease in Hong Kong: A Prospective Study
X. L. Zhu et al.
WORLD NEUROSURGERY (2014)
Estimating the lifetime economic burden of Parkinson's disease in Singapore
Y. J. Zhao et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease
Judith Dams et al.
MOVEMENT DISORDERS (2013)
An economic model of Parkinson's disease: Implications for slowing progression in the United States
Scott J. Johnson et al.
MOVEMENT DISORDERS (2013)
The current and projected economic burden of Parkinson's disease in the United States
Stacey L. Kowal et al.
MOVEMENT DISORDERS (2013)
Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients
Francisco Javier Carod-Artal et al.
PARKINSONISM & RELATED DISORDERS (2013)
Costs of Parkinson's Disease in a Privately Insured Population
Scott J. Johnson et al.
PHARMACOECONOMICS (2013)
Compliance with Pharmacotherapy and Direct Healthcare Costs in Patients with Parkinson's Disease: A Retrospective Claims Database Analysis
Florent F. Richy et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2013)
Drug and treatment costs in Parkinson's disease patients in Sweden
J. Lokk et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
An exercise intervention to prevent falls in Parkinson's: an economic evaluation
Emily Fletcher et al.
BMC HEALTH SERVICES RESEARCH (2012)
The economic cost of brain disorders in Europe
J. Olesen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease
Jens P. Reese et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia
Dong-Churl Suh et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease
Jan-Philipp Bach et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Parkinson's disease medication use and costs following deep brain stimulation
Frances M. Weaver et al.
MOVEMENT DISORDERS (2012)
Direct costs and survival of medicare beneficiaries with early and advanced parkinson's disease
A. Kaltenboeck et al.
PARKINSONISM & RELATED DISORDERS (2012)
Quality of life and burden in caregivers for patients with Parkinson's disease: concepts, assessment and related factors
Pablo Martinez-Martin et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study
Francesc Valldeoriola et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Economic burden of Parkinson's disease in Singapore
Y. J. Zhao et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Costs of illness and care in Parkinson's Disease: An evaluation in six countries
Sonja von Campenhausen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
The health-related, social, and economic consequences of parkinsonism: a controlled national study
Poul Jennum et al.
JOURNAL OF NEUROLOGY (2011)
A Cost Analysis of Intraoperative Microelectrode Recording During Subthalamic Stimulation for Parkinson's Disease
Shearwood McClelland
MOVEMENT DISORDERS (2011)
The Economic Impact of Cognitive Impairment in Parkinson's Disease
Corinna Vossius et al.
MOVEMENT DISORDERS (2011)
Projected Numbers of People With Movement Disorders in the Years 2030 and 2050
Jan-Philipp Bach et al.
MOVEMENT DISORDERS (2011)
Modelling the Cost Effectiveness of Treatments for Parkinson's Disease A Methodological Review
Judith Dams et al.
PHARMACOECONOMICS (2011)
The economic burden of advanced Parkinson’s disease: an analysis of a UK patient dataset
Leslie J. Findley et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson’s disease in the UK
Julia Lowin et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Early Retirement and Income Loss in Patients with Early and Advanced Parkinson's Disease
Scott Johnson et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2011)
The Use of Decision-Analytic Models in Parkinson's Disease
James Shearer et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2011)
Treatment of Advanced Parkinson's Disease in the United States A Cost-Utility Model
Huybert Groenendaal et al.
CLINICAL DRUG INVESTIGATION (2010)
Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany
Y. Winter et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Trends in resource utilization for Parkinson's disease in Germany
Yaroslav Winter et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial
Morten Munneke et al.
LANCET NEUROLOGY (2010)
Prevalence and Cost of Medication Nonadherence in Parkinson's Disease: Evidence from Administrative Claims Data
Keith L. Davis et al.
MOVEMENT DISORDERS (2010)
Costs of Parkinson's Disease and Antiparkinsonian Pharmacotherapy: An Italian Cohort Study
Yaroslav Winter et al.
NEURODEGENERATIVE DISEASES (2010)
Costs of Parkinson's disease in Eastern Europe: A Czech cohort study
Yaroslav Winter et al.
PARKINSONISM & RELATED DISORDERS (2010)
Pharmacotherapy in the management of early Parkinson's disease: cost-effectiveness and patient acceptability
Esther Cubo
CLINICOECONOMICS AND OUTCOMES RESEARCH (2010)
Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting An Economic Markov Model Evaluation
Alan Haycox et al.
DRUGS & AGING (2009)
Parkinson's disease and nursing home placement: the economic impact of the need for care
C. Vossius et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Capturing the Costs of End-of-Life Care: Comparisons of Multiple Sclerosis, Parkinson's Disease, and Dementia
Paul McCrone
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Costs of Illness in a Russian Cohort of Patients with Parkinson's Disease
Yaroslav Winter et al.
PHARMACOECONOMICS (2009)
Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden An Exploratory Study
Ivar Kristiansen et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2009)
Costs of brain disorders in Finland
M. Sillanpaa et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Cost effectiveness of pharmacotherapies in early Parkinson's disease
Karla M. Eggert et al.
CNS DRUGS (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Cost-Effectiveness of 123I-FP-CIT SPECT in the Differential Diagnosis of Essential Tremor and Parkinson's Disease in Italy
Angelo Antonini et al.
MOVEMENT DISORDERS (2008)
Burden, perceived health status, and mood among caregivers of Parkinson's disease patients
Pablo Martinez-Martin et al.
MOVEMENT DISORDERS (2008)
Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease
Francesc Valldeoriola et al.
MOVEMENT DISORDERS (2007)
Predicting the cost of Parkinson's disease
Paul McCrone et al.
MOVEMENT DISORDERS (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
Direct medical costs associated with Parkinson's disease: A population-based study
Cynthia L. Leibson et al.
MOVEMENT DISORDERS (2006)
Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China
Gang Wang et al.
MOVEMENT DISORDERS (2006)
A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia
Dennis John Cordato et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2006)
Drug costs for patients with Parkinson's disease in two different European countries
C Vossius et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Cost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland
J Hudry et al.
ANNALS OF PHARMACOTHERAPY (2006)
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease
V Fraix et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Economic burden associated with Parkinson's disease on elderly medicare beneficiaries
K Noyes et al.
MOVEMENT DISORDERS (2006)
Evaluating rehabilitation using cost-consequences analysis: an example in Parkinson's disease
H Gage et al.
CLINICAL REHABILITATION (2006)
Direct costs of managing Parkinson's disease in India: Concerns in a developing country
Mona Ragothaman et al.
MOVEMENT DISORDERS (2006)
A review of the health-related quality of life and economic impact of Parkinson's disease
Clare H. Dowding et al.
DRUGS & AGING (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs:: a prospective European study
M Péchevis et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Burden of illness in Parkinson's disease
DM Huse et al.
MOVEMENT DISORDERS (2005)
Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo*) compared to standard care in UK Parkinson's disease patients with wearing-off
LJ Findley et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Scientific evaluation of community-based Parkinson's disease nurse specialists on patient outcomes and health care costs
B Hurwitz et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2005)
Deep brain stimulation in late stage Parkinson's disease: a retrospective cost analysis in Germany
W Meissner et al.
JOURNAL OF NEUROLOGY (2005)
Cost of illness and its predictors for Parkinson's disease in Germany
AE Spottke et al.
PHARMACOECONOMICS (2005)
Pramipexole and levodopa in early Parkinson's disease - Dynamic changes in cost effectiveness
K Noyes et al.
PHARMACOECONOMICS (2005)
Economic and health-related quality of life considerations of new therapies in Parkinson's disease
LM Rubenstein et al.
PHARMACOECONOMICS (2001)
Health-related quality of life and healthcare utilisation in patients with Parkinson's disease - Impact of motor fluctuations and dyskinesias
RC Dodel et al.
PHARMACOECONOMICS (2001)
Share Paper
